Publication:
Metabolically reprograming pancreatic stellate cells using a novel nanomedicine for the treatment of pancreatic cancer

dc.contributor.coauthorSharbeen, G.
dc.contributor.coauthorAkerman, A.
dc.contributor.coauthorMcCarroll, J.
dc.contributor.coauthorBoyer, C.
dc.contributor.coauthorHolst, J.
dc.contributor.coauthorYoukhana, J.
dc.contributor.coauthorDavis, T. P.
dc.contributor.coauthorGoldstein, D.
dc.contributor.coauthorPhillips, P. A.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorErkan, Murat Mert
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:52:43Z
dc.date.issued2018
dc.description.indexedbyWOS
dc.description.issue10
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume47
dc.identifier.eissn1536-4828
dc.identifier.issn0885-3177
dc.identifier.quartileQ3
dc.identifier.urihttps://hdl.handle.net/20.500.14288/14879
dc.identifier.wos449304600230
dc.keywordsMetabolically reprograming
dc.keywordsPancreatic stellate cells
dc.keywordsNanomedicine
dc.keywordsPancreatic cancer
dc.language.isoeng
dc.publisherLippincott Williams and Wilkins (LWW)
dc.relation.ispartofPancreas
dc.subjectGastroenterology
dc.subjectHepatology
dc.titleMetabolically reprograming pancreatic stellate cells using a novel nanomedicine for the treatment of pancreatic cancer
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorErkan, Murat Mert
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files